Lagevrio (Molnupiravir)

Prescription medicineOnly Available By Prescription

What if I find a lower price with another pharmacy?

We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!

Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.

To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.

Terms & Conditions of Program

  • Guaranteed lowest price is only valid at the time of sale.
  • We will only match the current advertised price.
  • Products must be identical and in stock at the time of placing an order with a licensed mail order pharmacy. They must be an online Canadian pharmacy with an address in Canada.
  • Products must be authentic in brand and size (same manufacturer, same country of manufacture, same pack size, same strength and same quantity).
  • Products must be new. We cannot match the price of any used, short expiry or expired product.
  • Price match can only be issued over the phone with our customer service team. Please note at this time we cannot offer price matching for the products Ozempic or Saxenda.
What is a Generic Drug?

A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.

The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.

Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.

Description

Lagevrio (molnupiravir) is authorized for use under an Emergency Use Authorization to treat adults who are diagnosed with coronavirus disease 2019 (COVID-19).

Lagevrio is available in 200 mg capsules for oral administration.

Fact Table

Formula

C13H19N3O7

License

US FDA (Emergency Use Authorization); MHRA (UK)

Bioavailability

~100% (oral)

Legal status

Emergency use / Conditional approval

Chemical Name

Molnupiravir

Elimination half-life

~7 hours (active metabolite NHC)

Dosage (Strength)

200 mg capsules; 800 mg (4 capsules) orally every 12 hours for 5 days

Pregnancy

Not recommended (potential for fetal harm; animal studies show risk)

Brands

Lagevrio

Protein binding

<10%

PubChem CID

145996610

MedlinePlus

a622021

ChEBI

182433

ATC code

J05AX27

DrugBank

DB16335

KEGG

D12378

Routes of administration

Oral

Directions

Lagevrio should be taken as directed by your doctor. Any questions or concerns may be referred to your doctor or pharmacist.

The recommended dose of Lagevrio is to take 800 mg (or four 200 mg capsules) by mouth every 12 hours for 5 days. It may be taken with or without food.

Ingredients

The active ingredient in Lagevrio is molnupiravir.

Contraindications

There is limited data available, and contraindications have not been identified.

Cautions

  • Before you begin treatment with Lagevrio, inform your doctor of:
    • All the medications you take; no Lagevrio drug interactions have been identified according to the limited available data
    • Your allergies
    • Your current health problems
    • Your past medical history
    • Your pregnancy or breastfeeding status
  • Lagevrio is not recommended for pregnant patients; it can cause harm to an unborn fetus. Benefits must outweigh the risks before a doctor prescribes Lagevrio to a pregnant patient. If Lagevrio is prescribed to pregnant patients, the healthcare provider must document it in a pregnancy registry that monitors pregnancy outcomes in patients being treated with Lagevrio.
  • Patients of childbearing age should be counseled on the potential risk to an unborn baby and be advised to use effective contraception during treatment and for 4 days after taking the final dose.
  • Pregnancy must be confirmed before treatment initiation.
  • Lagevrio has been known to cause allergic reactions, including anaphylaxis. If an allergic reaction occurs, Lagevrio should be immediately discontinued.
  • Lagevrio is not authorized for use in patients younger than 18 years old, as it can impact bone and cartilage growth. The safety and effectiveness of Lagevrio has not been established in pediatric patients.

Side Effects

Lagevrio side effects include but are not limited to diarrhea, nausea, and dizziness. Inform your doctor of any bothersome or persistent side effects.

Here, you can buy Lagevrio. Talk to your doctor about Lagevrio.

Reference

Lagevrio. Rahway, NJ: Merck & Co., Inc.; 2023.




IMPORTANT NOTE: The information provided above is for general awareness and educational purposes only. It is not intended to diagnose, treat, or replace professional medical or veterinary advice. Always consult your physician, pharmacist, or veterinarian regarding the safety, suitability, and proper use of any medication for yourself or your pet.

product reviews icon Product Reviews